Mary E. Abood

11.3k citations

130 papers · 9.1k indexed · 1 hit paper · h-index 52

Impact in

Pharmacology top 0.02%
- Cannabis and Cannabinoid Research
Cellular and Molecular Neuroscience top 0.2%
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior

Papers in ⓘ

Pharmacology 84
- Cannabis and Cannabinoid Research 84
Cellular and Molecular Neuroscience 79
- Neuroscience and Neuropharmacology Research 45
- Neurotransmitter Receptor Influence on Behavior 32
- Neuropeptides and Animal Physiology 17

Co-authors: Billy R. Martin (17 shared papers)Allyn C. Howlett (6 shared papers)Vincent M. Showalter (6 shared papers)Tao Qing (11 shared papers)Haleli Sharir (11 shared papers)Patricia H. Reggio (28 shared papers)Sean D. McAllister (11 shared papers)George Kunos (5 shared papers)
Journals: Journal of Medicinal Chemistry (11 papers)Journal of Biological Chemistry (8 papers)Journal of Pharmacology and Experimental Therapeutics (8 papers)Molecular Pharmacology (7 papers)British Journal of Pharmacology (6 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Mary E. Abood

129 papers receiving 8.9k citations

Hit Papers

align trajectories log scale

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 2010 · 1.3k citations

Peers

Countries citing papers authored by Mary E. Abood

Since Specialization

Citations

This map shows the geographic impact of Mary E. Abood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Abood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Abood more than expected).

Fields of papers citing papers by Mary E. Abood

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary E. Abood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Abood. The network helps show where Mary E. Abood may publish in the future.

Co-authors

The 25 scholars most cited alongside Mary E. Abood, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mary E. Abood Line = papers co-authored together Mary E. Abood links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 130 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 Pharmacological Reviews ·Roger G. Pertwee, Allyn C. Howlett, Mary E. Abood, S P H Alexander, Vincenzo Di Marzo, Maurice R. Elphick, Peter J. Greasley, Harald S. Hansen, George Kunos, Ken Mackie, Raphael Mechoulam, Ruth A. Ross Hit paper breakdown →	2010	1284
2	Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. Journal of Pharmacology and Experimental Therapeutics ·Vincent M. Showalter, David M. Compton, BR Martin, Mary E. Abood	1996	492
3	Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB¹receptors on peripheral sympathetic nerves British Journal of Pharmacology ·Edward J.N. Ishac, Jiang Liu, Kristy D. Lake, K Varga, Mary E. Abood, George Kunos	1996	288
4	CB 1 and CB 2 Receptor Pharmacology Advances in pharmacology ·Allyn C. Howlett, Mary E. Abood	2017	263
5	3-(1′,1′-Dimethylbutyl)-1-deoxy-Δ8-THC and related compounds: synthesis of selective ligands for the CB2 receptor Bioorganic & Medicinal Chemistry ·John W. Huffman, John Liddle, Shu Yu, Mie Mie Aung, Mary E. Abood, Jenny L. Wiley, Billy R. Martin	1999	248
6	Atypical Responsiveness of the Orphan Receptor GPR55 to Cannabinoid Ligands Journal of Biological Chemistry ·Ankur Kapur, Pingwei Zhao, Haleli Sharir, Yushi Bai, Marc G. Caron, Larry S. Barak, Mary E. Abood	2009	224
7	Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. Molecular Pharmacology ·Norbert E. Kaminski, Mary E. Abood, F Kessler, Billy R. Martin, Anthony R. Schatz	1992	215
8	Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor binding Drug and Alcohol Dependence ·Mie Mie Aung, Graeme Griffin, John W. Huffman, Ming‐Jung Wu, Cheryl Keel, Bin Yang, Vincent M. Showalter, Mary E. Abood, Billy R. Martin	2000	208
9	Pharmacological characterization of GPR55, a putative cannabinoid receptor Pharmacology & Therapeutics ·Haleli Sharir, Mary E. Abood	2010	183
10	Neurobiology of marijuana abuse Trends in Pharmacological Sciences ·Mary E. Abood, Billy R. Martin	1992	179
11	Functional homology between signal-coupling proteins. Cholera toxin inactivates the GTPase activity of transducin. Journal of Biological Chemistry ·Mary E. Abood, James B. Hurley, M C Pappone, Henry R. Bourne, Lubert Stryer	1982	174
12	An Aromatic Microdomain at the Cannabinoid CB₁ Receptor Constitutes an Agonist/Inverse Agonist Binding Region Journal of Medicinal Chemistry ·Sean D. McAllister, Gulrukh Rizvi, Sharon Anavi‐Goffer, Dow P. Hurst, Judy Barnett‐Norris, Diane L. Lynch, Patricia H. Reggio, Mary E. Abood	2003	161
13	Cloning and Pharmacological Characterization of the Rat CB2 Cannabinoid Receptor Journal of Pharmacology and Experimental Therapeutics ·Greg P. Griffin, Tao Qing, Mary E. Abood	2000	160
14	Synthesis and Pharmacology of a Very Potent Cannabinoid Lacking a Phenolic Hydroxyl with High Affinity for the CB2 Receptor Journal of Medicinal Chemistry ·John W. Huffman, Shu Yu, Vincent M. Showalter, Mary E. Abood, Jenny L. Wiley, David M. Compton, Billy R. Martin, R.D. Bramblett, Patricia H. Reggio	1996	142
15	The endocannabinoid system as a target for the treatment of neurodegenerative disease British Journal of Pharmacology ·Emma L. Scotter, Mary E. Abood, Michelle Glass	2010	141
16	Activation of GPR18 by cannabinoid compounds: a tale of biased agonism British Journal of Pharmacology ·Linda Console‐Bram, Eugen Brailoiu, G. Cristina Brailoiu, Haleli Sharir, Mary E. Abood	2014	134
17	Structural Mimicry in Class A G Protein-coupled Receptor Rotamer Toggle Switches Journal of Biological Chemistry ·Sean D. McAllister, Dow P. Hurst, Judy Barnett‐Norris, Diane L. Lynch, Patricia H. Reggio, Mary E. Abood	2004	128
18	AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis European Journal of Pharmacology ·Kathline Kim, Dan H. Moore, Alexandros Makriyannis, Mary E. Abood	2006	127
19	Cannabinoid receptors: nomenclature and pharmacological principles Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Linda Console‐Bram, Jahan P. Marcu, Mary E. Abood	2012	124
20	Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system European Journal of Pharmacology ·Graeme Griffin, Emma J Wray, Tao Qing, Sean D. McAllister, William K Rorrer, MieMie Aung, Billy R. Martin, Mary E. Abood	1999	121

About Mary E. Abood

Mary E. Abood is a scholar working on Pharmacology, Cellular and Molecular Neuroscience, Toxicology, Physiology and Molecular Biology, having authored 130 papers that have together received 9.1k indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (84 papers), Neuroscience and Neuropharmacology Research (45 papers), Receptor Mechanisms and Signaling (38 papers), Neurotransmitter Receptor Influence on Behavior (32 papers), Pharmacological Receptor Mechanisms and Effects (29 papers), Pancreatic function and diabetes (17 papers), Neuropeptides and Animal Physiology (17 papers) and Forensic Toxicology and Drug Analysis (9 papers). The work is most often cited by research in Pharmacology (6.7k citations), Cellular and Molecular Neuroscience (4.5k citations), Toxicology (854 citations), Endocrine and Autonomic Systems (769 citations) and Biological Psychiatry (214 citations). Mary E. Abood has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Billy R. Martin, Allyn C. Howlett, Vincent M. Showalter, Tao Qing, Haleli Sharir, Patricia H. Reggio, Sean D. McAllister, George Kunos, David M. Compton and Eugen Brailoiu. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Biological Chemistry, Journal of Pharmacology and Experimental Therapeutics, Molecular Pharmacology and British Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact